Hydralin IntimiFlor, gélules à avaler
Food supplement declared in France, decision dated 11 June 2026
Hydralin IntimiFlor, gélules à avaler, from BAYER HEALTHCARE SAS, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Lactobacillus Acidophilus LA14 1,000,000,000 (unit not declared) per day, Lactobacillus Plantarum PBS0677 1,000,000,000 (unit not declared) per day, Lactobacillus Rhamnosus LRH020 1,000,000,000 (unit not declared) per day, Bifidobacterium Lactis BL050 1,000,000,000 (unit not declared) per day, Vitamin B2 (riboflavin). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Hydralin IntimiFlor
- Food business operator placing the product on the market
- BAYER HEALTHCARE SAS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1
- Directions for use
- 1 gélule par jour à prendre avec un verre d’eau au minimum 30 minutes avant le repas
- Intended populations
- Women
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : Confort intime
- Flavourings
- NA
Declaration 364763, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Micro-organisms
| Strain | Per day |
|---|---|
| Lactobacillus Acidophilus LA14 | 1,000,000,000 (unit not declared) |
| Lactobacillus Plantarum PBS0677 | 1,000,000,000 (unit not declared) |
| Lactobacillus Rhamnosus LRH020 | 1,000,000,000 (unit not declared) |
| Bifidobacterium Lactis BL050 | 1,000,000,000 (unit not declared) |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| riboflavin | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
Additives
E464, E471, E470b
Other ingredients
amidon de maïs
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
L’avis d’un professionnel de santé est conseillé pour la femme enceinte ou allaitante, ainsi que pour les femmes souffrant de déficit immunitaire. Tenir hors de la portée des jeunes enfants. Ne pas utiliser en cas d’hypersensibilité à l’un des ingrédients. Ne pas dépasser la dose journalière recommandée. Conserver à une température ne dépassant pas 25°C.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Hydralin IntimiFlor, gélules à avaler Hydralin IntimiFlor, declared in 2023, earlier declaration, replaced by the 2026 declaration : different composition: 4 ingredient(s) added, 4 missing
Brand : Hydralin IntimiFlor
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Hydralin IntimiFlor, gélules à avaler: composition and regulation”, https://compoatlas.com/en/supplements/products/364763-hydralin-intimiflor-gelules-a-avaler, updated 15 November 2026.